U.S. markets close in 1 hour 13 minutes
  • S&P 500

    4,243.42
    +18.63 (+0.44%)
     
  • Dow 30

    33,943.51
    +66.54 (+0.20%)
     
  • Nasdaq

    14,214.37
    +72.89 (+0.52%)
     
  • Russell 2000

    2,285.59
    -0.51 (-0.02%)
     
  • Crude Oil

    73.08
    -0.58 (-0.79%)
     
  • Gold

    1,779.70
    -3.20 (-0.18%)
     
  • Silver

    25.89
    -0.14 (-0.52%)
     
  • EUR/USD

    1.1943
    +0.0019 (+0.16%)
     
  • 10-Yr Bond

    1.4800
    -0.0040 (-0.27%)
     
  • GBP/USD

    1.3945
    +0.0012 (+0.09%)
     
  • USD/JPY

    110.6270
    +0.3290 (+0.30%)
     
  • BTC-USD

    33,171.28
    +526.44 (+1.61%)
     
  • CMC Crypto 200

    790.23
    -4.10 (-0.52%)
     
  • FTSE 100

    7,090.01
    +27.72 (+0.39%)
     
  • Nikkei 225

    28,884.13
    +873.20 (+3.12%)
     

This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon

·4 min read
This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Vertex Pharmaceuticals (NASDAQ: VRTX) is the leader in cystic fibrosis (CF) treatment -- and it expects to hold that title until at least the late 2030s. The biotech company may be about to prove that, yes, it can. Vertex CEO Reshma Kewalramani made a statement about one of the company's most innovative, exciting programs during the recent earnings call.